An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.

Kostova, Y; Mantwill, K; Holm, P S; Anton, M

doi:10.1038/cgt.2014.67

Benutzer: Gast

2015

Zurück
Zurück zum Anfang der Trefferliste
Dauerhafter Link zum angezeigten Objekt

Titel:: An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Dokumenttyp:: Journal Article; Research Support, Non-U.S. Gov't
Autor(en):: Kostova, Y; Mantwill, K; Holm, P S; Anton, M
Abstract:: We investigated the novel recombinant oncolytic adenovirus Ad-delo-sr39TK-RGD, armed with a mutant herpes simplex virus type 1 thymidine kinase (HSV1-sr39TK) as a suicide gene, and explored its antitumor efficacy in combination with HSV1-sr39TK/ganciclovir (GCV) gene therapy and temozolomide (TMZ). Ad-delo-sr39TK-RGD is an E1-mutated conditionally replicating adenovirus dependent on the human Y-box binding protein 1 (YB-1). Thus, we utilized the YB-1 dependency of the vector to target human glioma cells in vitro, using two-dimensional cell culture and three-dimensional multicellular spheroids, and demonstrated the strong replication competence and oncolytic potential of the virus. The cytotoxicity mediated by HSV1-sr39TK and its prodrug GCV enhanced the oncolytic effect even at <0.1 ?g ml(-1) GCV and induced cell killing of > 95% after adding GCV 0-1 days following infection. An increased bystander effect of viral replication and GCV in co-cultured infected and uninfected cells was observed. Co-administrating Ad-delo-sr39TK-RGD with TMZ and GCV, spheroid growth was reduced drastically. Gamma counting of infected spheroids demonstrated successful accumulation of the radiotracer (18)F-labeled 9-[4-fluoro-3-(hydroxymethyl)butyl]guanine mediated by HSV1-sr39TK. Hence, our results show that the combination of YB-1-dependent virotherapy with suicide genes and TMZ effectively induces glioma cell killing and may allow for in vivo non-invasive imaging within a limited time frame.
Zeitschriftentitel:: Cancer Gene Ther
Jahr:: 2015
Band / Volume:: 22
Heft / Issue:: 1
Seitenangaben Beitrag:: 30-43
Sprache:: eng
Volltext / DOI:: doi:10.1038/cgt.2014.67
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/25501992
Print-ISSN:: 0929-1903
TUM Einrichtung:: Institut für Experimentelle Onkologie und Therapieforschung
BibTeX

Vorkommen:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Ehemalige Einrichtungen Institut für Experimentelle Onkologie und Therapieforschung 2015

mediaTUM Gesamtbestand Hochschulbibliographie 2015 Fakultäten Medizin Institut für Experimentelle Onkologie und Therapieforschung